Skip to main content
. Author manuscript; available in PMC: 2019 Jul 12.
Published in final edited form as: J Viral Hepat. 2017 Dec 27;25(5):465–472. doi: 10.1111/jvh.12836

TABLE 1.

Baseline demographics and patient characteristics

Responders
(n = 8)		 Relapsers
(n = 6)		 P-value
Age, years (median, range)   46.5 (21–65)   45.5 (29–48) .6040
Male sex (n, %)   8 (100%)   6 (100%) -
ALT, mg/dL (median, range) 206.5 (92–564) 183.0 (201–284) .5181
AST, mg/dL (median, range) 134.0 (56–395) 103.5 (83–162) .6982
Total bilirubin, mg/dL (median, range)   0.7 (0.4–2.1)   0.7 (0.6–1.1) .6455
IFNL3 genotype (CC) (n, %)   1 (12.5%)   0 (0) 1.0000
IFNL3 genotype (CT/TT) (n, %)   7/1 (88%/12%)   6/0 (100%/0%) .5590
HIV viral load, copies/mL (median, range)     <50 (<50–80)     <50 (<50–<50) .3865
CD4 count, cells/mm3 (median, range) 458.0 (331–652) 473.5 (213–618) .5186
HCV genotype 1 (n, %)      7 (88%)      6 (100%) 1.0000
HCV viral load, log10 IU/mL (median, range)   6.22 (4.48–6.87)   6.50 (5.82–7.28) .3662